Rickets

Rickets is a condition in which bones fail to harden properly because the body lacks enough vitamin D, calcium, or phosphate. It is most common in young children but can affect adults, particularly those with severe or prolonged deficiency. In South and Southeast Asia, low dietary intake and limited sun exposure from indoor lifestyles contribute to its continued prevalence despite the abundant sunlight in the region.

Medicine used to treat Rickets

Alfacip

Alfacalcidol

0.25 · 0.5mcg

Formulated to manage calcium levels, this treatment is indicated to support bone health by regulating mineral metabolism.

From $0.62 / capsule View

Why bones weaken in rickets

Vitamin D controls how the gut absorbs calcium and phosphate, the minerals that give bone its rigidity. Without enough of it, mineralisation stalls and bones stay rubbery. Weight-bearing legs often bow outward, the wrists and ankles thicken, and children may have a soft spot on the skull that takes longer than normal to close. Muscle weakness, dental delays, and slow growth are other common signs.

Treating the underlying deficiency

The cornerstone of treatment is restoring vitamin D to working levels. Alfacalcidol is an activated form of vitamin D used when the body cannot convert standard vitamin D efficiently, which is the case in some hereditary and kidney-related forms of rickets. General bone health support, including adequate calcium intake, is maintained alongside vitamin D therapy throughout recovery.